Spots Global Cancer Trial Database for topotecan hydrochloride
Every month we try and update this database with for topotecan hydrochloride cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia | NCT00003735 | Leukemia | topotecan hydro... | - 21 Years | Children's Oncology Group | |
| Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer | NCT00550784 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | filgrastim cisplatin cyclophosphamid... melphalan paclitaxel topotecan hydro... TdT-mediated dU... gene expression... immunohistochem... pharmacological... peripheral bloo... | - 60 Years | City of Hope Medical Center | |
| Chemotherapy in Treating Patients With Recurrent Malignant Glioma | NCT00002986 | Brain and Centr... | carmustine topotecan hydro... | 18 Years - | Duke University | |
| Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia | NCT00003619 | Chronic Myelopr... Leukemia Myelodysplastic... Thrombocytopeni... | filgrastim vitamin E busulfan cytarabine etoposide fludarabine pho... isotretinoin topotecan hydro... bone marrow abl... peripheral bloo... | 19 Years - 90 Years | National Cancer Institute (NCI) | |
| Study of Temsirolimus, Topotecan, and Bortezomib | NCT00770731 | Advanced Cancer | Torisel (Temsir... Hycamtin (Topot... Velcade (Bortez... | - | M.D. Anderson Cancer Center | |
| Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer | NCT00087048 | Lung Cancer | topotecan hydro... | 18 Years - | Case Comprehensive Cancer Center | |
| Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma | NCT00567567 | Localized Resec... Localized Unres... Recurrent Neuro... Regional Neurob... Stage 4 Neurobl... Stage 4S Neurob... | Autologous Hema... Carboplatin Cisplatin Cyclophosphamid... Doxorubicin Hyd... Etoposide External Beam R... Filgrastim Isotretinoin Laboratory Biom... Melphalan Peripheral Bloo... Pharmacological... Thiotepa Topotecan Hydro... Vincristine Sul... | - 30 Years | Children's Oncology Group | |
| Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia | NCT00002588 | Leukemia | etoposide topotecan hydro... | 18 Years - | Case Comprehensive Cancer Center | |
| Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia | NCT00003340 | Leukemia | cyclophosphamid... topotecan hydro... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer | NCT00005029 | Ovarian Cancer Primary Periton... | topotecan hydro... | - 120 Years | GOG Foundation | |
| Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma | NCT00107471 | Brain Tumors Central Nervous... | filgrastim topotecan hydro... radiation thera... | 3 Years - 21 Years | Children's Oncology Group | |
| Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma | NCT00410631 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide phosp... ifosfamide isotretinoin melphalan topotecan hydro... vincristine sul... vindesine autologous hema... conventional su... peripheral bloo... iobenguane I 13... radiation thera... | - 21 Years | National Cancer Institute (NCI) | |
| Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome | NCT00003415 | Leukemia Myelodysplastic... | amifostine trih... topotecan hydro... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer. | NCT00003943 | Carcinoma of Un... Lung Cancer | filgrastim carboplatin cyclophosphamid... paclitaxel topotecan hydro... peripheral bloo... | 18 Years - | Fox Chase Cancer Center | |
| Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | NCT00004188 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... doxorubicin hyd... etoposide isotretinoin melphalan topotecan hydro... vincristine sul... autologous bone... bone marrow abl... conventional su... peripheral bloo... radiation thera... | - 30 Years | Children's Oncology Group | |
| Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders | NCT00588991 | Adult Acute Meg... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Chronic Myeloid... Chronic Myelomo... de Novo Myelody... Essential Throm... Hematopoietic a... Myelodysplastic... Polycythemia Ve... Recurrent Adult... Recurrent Adult... Secondary Myelo... | Carboplatin Laboratory Biom... Topotecan Hydro... Veliparib | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | NCT00006012 | Drug/Agent Toxi... Lung Cancer Radiation Toxic... | filgrastim amifostine trih... cisplatin etoposide paclitaxel topotecan hydro... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer | NCT00005029 | Ovarian Cancer Primary Periton... | topotecan hydro... | - 120 Years | GOG Foundation | |
| High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer | NCT00002948 | Unspecified Adu... | filgrastim topotecan hydro... bone marrow abl... peripheral bloo... | 18 Years - | Yale University | |
| Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | NCT00634244 | Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult... | alvocidib mitoxantrone hy... carboplatin cytarabine sirolimus etoposide topotecan hydro... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Pilot Study of Topotecan/Vincristine With Subconjunctival Carboplatin for Patients With Bilateral Retinoblastoma | NCT00980551 | Retinoblastoma | subtenon Carbop... Topotecan Hydro... Vincristine Filgrastim | - 10 Years | Children's Hospital Medical Center, Cincinnati | |
| Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer | NCT00006454 | Fallopian Tube ... Ovarian Cancer | carboplatin paclitaxel topotecan hydro... | 18 Years - 120 Years | AGO Study Group | |
| Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer | NCT00114166 | Fallopian Tube ... Ovarian Cancer Primary Periton... | topotecan hydro... | 18 Years - 120 Years | GOG Foundation | |
| A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy | NCT01840943 | Epithelial Ovar... | CAELYX Topotecan HCl | 18 Years - | Xian-Janssen Pharmaceutical Ltd. | |
| Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer | NCT00005051 | Ovarian Cancer | carboplatin cisplatin paclitaxel topotecan hydro... | 18 Years - | NYU Langone Health | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | NCT00033696 | Lung Cancer | filgrastim carboplatin etoposide paclitaxel topotecan hydro... radiation thera... | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia | NCT00002693 | Leukemia Neutropenia | filgrastim carboplatin topotecan hydro... | 18 Years - | Mayo Clinic | |
| Bortezomib and Topotecan in Treating Patients With Advanced Solid Tumors | NCT00388089 | Lung Cancer Unspecified Adu... | bortezomib topotecan hydro... flow cytometry immunoenzyme te... immunohistochem... laboratory biom... | 18 Years - | University of California, Davis | |
| Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor Therapy | NCT05295589 | Platinum-Refrac... Platinum-Refrac... Platinum-Refrac... Recurrent Fallo... Recurrent Fallo... Recurrent Ovari... Recurrent Ovari... Recurrent Plati... Recurrent Plati... Recurrent Plati... Recurrent Prima... Recurrent Prima... | Computed Tomogr... Copanlisib Hydr... Magnetic Resona... Olaparib Paclitaxel Pegylated Lipos... Topotecan Hydro... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer | NCT00003297 | Ovarian Cancer | mitoxantrone hy... thiotepa topotecan hydro... peripheral bloo... | 18 Years - | Georgetown University | |
| R115777 Plus Topotecan in Treating Patients With Advanced Solid Tumors | NCT00005990 | Unspecified Adu... | tipifarnib topotecan hydro... | 18 Years - | NYU Langone Health | |
| Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma | NCT00392340 | Neuroblastoma | filgrastim doxorubicin hyd... topotecan hydro... vincristine sul... | 1 Year - 20 Years | National Cancer Institute (NCI) | |
| Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors | NCT00541138 | Brain and Centr... Metastatic Canc... Unspecified Adu... | carboplatin tamoxifen citra... topotecan hydro... pharmacological... | 18 Years - | City of Hope Medical Center | |
| Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | NCT00004186 | Lung Cancer | carboplatin etoposide ifosfamide topotecan hydro... radiation thera... | - | University of Alabama at Birmingham | |
| Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma | NCT00526318 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide phosp... ifosfamide isotretinoin melphalan topotecan hydro... vincristine sul... vindesine autologous hema... iobenguane I 13... radiation thera... | - 21 Years | National Cancer Institute (NCI) | |
| Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus | NCT00003156 | Sarcoma | topotecan hydro... | - | GOG Foundation | |
| Tivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors | NCT01654965 | Adult Solid Neo... | Laboratory Biom... Pegfilgrastim Pharmacological... Tivantinib Topotecan Hydro... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer | NCT00004186 | Lung Cancer | carboplatin etoposide ifosfamide topotecan hydro... radiation thera... | - | University of Alabama at Birmingham | |
| Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor Therapy | NCT05295589 | Platinum-Refrac... Platinum-Refrac... Platinum-Refrac... Recurrent Fallo... Recurrent Fallo... Recurrent Ovari... Recurrent Ovari... Recurrent Plati... Recurrent Plati... Recurrent Plati... Recurrent Prima... Recurrent Prima... | Computed Tomogr... Copanlisib Hydr... Magnetic Resona... Olaparib Paclitaxel Pegylated Lipos... Topotecan Hydro... | 18 Years - | National Cancer Institute (NCI) | |
| Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma | NCT01798004 | Ganglioneurobla... Stage 1 Neurobl... Stage 2 Neurobl... Stage 2A Neurob... Stage 2B Neurob... Stage 3 Neurobl... Stage 4 Neurobl... Stage 4S Neurob... | Autologous Hema... Busulfan Cisplatin Cyclophosphamid... Doxorubicin Hyd... Etoposide External Beam R... Filgrastim Laboratory Biom... Melphalan Mesna Peripheral Bloo... Pharmacological... Topotecan Hydro... Vincristine Sul... | - 30 Years | Children's Oncology Group | |
| Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer | NCT00003281 | Lung Cancer | paclitaxel topotecan hydro... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia | NCT00005962 | Leukemia | sargramostim cyclophosphamid... cytarabine gemtuzumab ozog... liposomal dauno... topotecan hydro... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer | NCT00005026 | Ovarian Cancer Primary Periton... | carboplatin paclitaxel topotecan hydro... | - | GOG Foundation | |
| A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy | NCT01840943 | Epithelial Ovar... | CAELYX Topotecan HCl | 18 Years - | Xian-Janssen Pharmaceutical Ltd. | |
| Bortezomib and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors | NCT00541359 | Unspecified Adu... | bortezomib topotecan hydro... immunohistochem... pharmacological... | 18 Years - | City of Hope Medical Center | |
| Topotecan in Treating Patients With Recurrent Brain Tumors | NCT00003372 | Brain and Centr... | topotecan hydro... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia | NCT00005962 | Leukemia | sargramostim cyclophosphamid... cytarabine gemtuzumab ozog... liposomal dauno... topotecan hydro... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer | NCT00006032 | Breast Cancer | etoposide ifosfamide topotecan hydro... peripheral bloo... | 18 Years - 64 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer | NCT00287911 | Cervical Cancer | cisplatin topotecan hydro... brachytherapy radiation thera... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma | NCT00070200 | Neuroblastoma | filgrastim cisplatin cyclophosphamid... doxorubicin hyd... etoposide isotretinoin melphalan topotecan hydro... vincristine sul... conventional su... peripheral bloo... radiation thera... | - 30 Years | Children's Oncology Group | |
| R115777 Plus Topotecan in Treating Patients With Advanced Solid Tumors | NCT00005990 | Unspecified Adu... | tipifarnib topotecan hydro... | 18 Years - | NYU Langone Health | |
| 7-hydroxystaurosporine and Topotecan Hydrochloride in Treating Patients With Relapsed or Progressed Small Cell Lung Cancer | NCT00098956 | Extensive Stage... Recurrent Small... | topotecan hydro... 7-hydroxystauro... | 18 Years - | National Cancer Institute (NCI) | |
| UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer | NCT00072267 | Fallopian Tube ... Ovarian Cancer Primary Periton... | 7-hydroxystauro... topotecan hydro... | 18 Years - | University Health Network, Toronto | |
| Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma | NCT00004006 | Retinoblastoma | filgrastim carboplatin cyclophosphamid... doxorubicin hyd... etoposide topotecan hydro... autologous bone... radiation thera... | - 15 Years | St. Jude Children's Research Hospital | |
| Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | NCT00033696 | Lung Cancer | filgrastim carboplatin etoposide paclitaxel topotecan hydro... radiation thera... | 18 Years - 120 Years | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome | NCT00003827 | Leukemia Myelodysplastic... | amifostine trih... cytarabine topotecan hydro... | 16 Years - | National Cancer Institute (NCI) | |
| Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma | NCT00392340 | Neuroblastoma | filgrastim doxorubicin hyd... topotecan hydro... vincristine sul... | 1 Year - 20 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer | NCT00005612 | Ovarian Cancer | filgrastim carboplatin cyclophosphamid... etoposide paclitaxel topotecan hydro... peripheral bloo... | 18 Years - 65 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| Combination Chemotherapy in Treating Young Patients With Nonmetastatic Rhabdomyosarcoma | NCT00379457 | Sarcoma | dactinomycin carboplatin cyclophosphamid... doxorubicin hyd... etoposide ifosfamide topotecan hydro... vincristine sul... vinorelbine tar... conventional su... radiation thera... | - 20 Years | National Cancer Institute (NCI) | |
| Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer | NCT01266447 | Cervical Adenoc... Cervical Adenos... Cervical Small ... Cervical Squamo... Recurrent Cervi... Stage III Cervi... Stage IVA Cervi... Stage IVB Cervi... | Filgrastim Laboratory Biom... Pegfilgrastim Topotecan Hydro... Veliparib | 18 Years - | National Cancer Institute (NCI) | |
| Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer | NCT00003281 | Lung Cancer | paclitaxel topotecan hydro... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Topotecan in Treating Patients With Recurrent, Progressive, or Refractory Cancer That is Metastatic to the Lining Around the Brain | NCT00025311 | Brain and Centr... | topotecan hydro... | - 65 Years | NYU Langone Health | |
| A Dose Finding Phase I Trial of the Combination of Topotecan and PS-341, a Novel Proteasome Inhibitor, in Advanced Malignancies | NCT00068484 | Unspecified Adu... | topotecan hydro... bortezomib pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia | NCT00003340 | Leukemia | cyclophosphamid... topotecan hydro... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer | NCT00276796 | Cervical Cancer | cisplatin paclitaxel topotecan hydro... | 18 Years - | GOG Foundation | |
| Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer | NCT00287963 | Lung Cancer | topotecan hydro... vinorelbine tar... | 18 Years - 120 Years | Medical University of South Carolina | |
| Carboplatin and Topotecan in Treating Patients With Relapsed or Metastatic Cervical Cancer | NCT00807079 | Cervical Cancer | carboplatin topotecan hydro... | 18 Years - | ARCAGY/ GINECO GROUP | |
| Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma | NCT01798004 | Ganglioneurobla... Stage 1 Neurobl... Stage 2 Neurobl... Stage 2A Neurob... Stage 2B Neurob... Stage 3 Neurobl... Stage 4 Neurobl... Stage 4S Neurob... | Autologous Hema... Busulfan Cisplatin Cyclophosphamid... Doxorubicin Hyd... Etoposide External Beam R... Filgrastim Laboratory Biom... Melphalan Mesna Peripheral Bloo... Pharmacological... Topotecan Hydro... Vincristine Sul... | - 30 Years | Children's Oncology Group | |
| Bortezomib and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors | NCT00541359 | Unspecified Adu... | bortezomib topotecan hydro... immunohistochem... pharmacological... | 18 Years - | City of Hope Medical Center | |
| Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs | NCT03896503 | Bladder Small C... Extensive Stage... Extrapulmonary ... Limited Stage L... Platinum-Resist... Platinum-Sensit... Prostate Small ... Recurrent Lung ... | Berzosertib Biopsy Biospecimen Col... Computed Tomogr... Topotecan Hydro... | 18 Years - | National Cancer Institute (NCI) | |
| Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer | NCT02502266 | Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Ovarian Clear C... Ovarian Endomet... Ovarian Seromuc... Ovarian Serous ... Ovarian Transit... Ovarian Undiffe... Primary Periton... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... | Cediranib Cediranib Malea... Computed Tomogr... Magnetic Resona... Olaparib Paclitaxel Pegylated Lipos... Questionnaire A... Topotecan Topotecan Hydro... | 18 Years - | National Cancer Institute (NCI) | |
| UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer | NCT00072267 | Fallopian Tube ... Ovarian Cancer Primary Periton... | 7-hydroxystauro... topotecan hydro... | 18 Years - | University Health Network, Toronto | |
| Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma | NCT00960739 | Neuroblastoma | Topotecan hydro... Autologous hema... iobenguane I 13... total-body irra... | 1 Year - 20 Years | Centre Oscar Lambret | |
| Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma | NCT00006125 | Lymphoma | doxorubicin hyd... topotecan hydro... | - | Alliance for Clinical Trials in Oncology | |
| Topotecan in Treating Children With Refractory Leukemia | NCT00002705 | Leukemia | topotecan hydro... | - 20 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | NCT00003944 | Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | filgrastim carboplatin cyclophosphamid... paclitaxel topotecan hydro... peripheral bloo... | 18 Years - | Fox Chase Cancer Center | |
| Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer | NCT00003281 | Lung Cancer | paclitaxel topotecan hydro... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors | NCT00004979 | Unspecified Adu... | paclitaxel topotecan hydro... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer | NCT00005026 | Ovarian Cancer Primary Periton... | carboplatin paclitaxel topotecan hydro... | - | GOG Foundation | |
| Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer | NCT00002913 | Brenner Tumor Ovarian Clear C... Ovarian Endomet... Ovarian Mixed E... Ovarian Mucinou... Ovarian Serous ... Ovarian Undiffe... Stage III Ovari... Stage IV Ovaria... | paclitaxel cisplatin topotecan hydro... filgrastim | - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
